The goal of this activity is for learners to be better able to apply biomarker testing for patients with ER-positive/HER2-negative BC progressing on an AI +/- CDK 4/6 inhibitors to inform treatment decisions.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits
MOC types
ABIM — Medical KnowledgeUp to 0.5 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 283 - 299 Market St.
Pricing
100% of listed courses are free
300 of a sample of 300 are free · 1,253 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Clinical Informatics
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Obstetrics & Gynecology
- Ophthalmology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Gastroenterology
- Pediatric Neurology
- Plastic & Reconstructive Surgery
- Preventive Medicine
- Primary Care Sports Medicine
- Pulmonary Disease
- Rheumatology
- Rhinology
- Sleep Medicine
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedJan 23, 2026
-
Last day to claim creditJan 24, 2027 4 months left
-
Medscape, LLC Current and Future Oral SERD Strategies in the Management of ER+/HER2 MBC: Analyzing the Clinical Data
-
Medscape, LLC Enhancing Clinical Understanding of Oral SERD-Based Therapies for Patients With ER-Positive/HER2-Negative MBC
-
Medscape, LLC Patients Progressing on an AI +/ CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies
-
Med Learning Group Emerging Oral SERDs in Early HR+/HER2- Breast Cancer: Biomarkers, Shared Decision-Making, and Practical Management of Investigational Therapies
-
Physicians’ Education Resource Cases and Conversations: Optimizing Oral SERD-Based Therapy After CDK4/6 Inhibition in HR+/HER2- MBC
-
Clinical Care Options, LLC (dba Decera Clinical Education) Next-Generation Oral SERDs in Adjuvant ER-Positive/HER2-Negative Early Breast Cancer: Interrogating the Evidence for Clinical Integration
